INSIGHTS ON CLINICAL TRIAL DESIGN

• The Role Of Oncology Biomarkers In Personalizing Hematology Treatment Plans

  Oncology biomarkers guide personalized treatment and help track disease changes. Learn more about how advancements like liquid biopsies improve precision care.

• Winning Enrollment In A Competitive CNS Trial Landscape

  Many CNS trials today operate in a highly competitive environment. Enrollment success is shaped by the decisions teams make under these constraints.

• Community-Focused Site Networks Increase Access And Trial Reach

  Community-based site networks enhance clinical trial equity by engaging diverse populations, improving enrollment, retention, and developing therapies effective across varied patient groups.

• Ensure Seamless Clinical Trial Transition Across Global Markets

  If you want to increase speed and reduce costs while still procuring high-quality data for your clinical trial, consider the impact of launching an early-phase clinical trial in Australia.

• The Expanding Role Of GLP-1 Receptor Agonists In CNS Clinical Research

  7/31/2026

  Metabolic drugs show promise for brain disorders. Emerging evidence suggests they reduce addictive behaviors and may help treat neurodegenerative diseases, opening new pathways for addiction and neurological care.

• A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data

  2/25/2025

  Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.

• How In-Home Trials Can Shift The Pediatric Rare Disease Research Landscape

  1/6/2026

  DCT solutions are not just about bringing the trial to the patient’s home and reducing logistical burdens, but also strengthening the family-researcher connection.

• Practical Strategies For Diverse Trial Recruitment

  11/11/2024

  The clock is ticking on the requirement for pharmaceutical companies to include FDA-mandated diversity action plans for pivotal studies in clinical trials.

• Protocol Design Choices That Trigger IRB And Regulatory Requirements

  8/20/2026

  Learn how protocol choices like AI, adaptive designs, and decentralized methods impact IRB review, participant protections, consent, and key regulatory requirements in clinical research.